Anticorps anti-CD19 humain/souris/rat avec preuve testée par collaborateur pour IHC.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Human/Mouse/Rat CD19 Antibody is a research-use antibody from Elabscience for studying CD19 in IHC workflows with listed reactivity for Human, Mouse, Rat. Specifications and supporting documents below should be reviewed when planning the experiment.
Fully tested in-house by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Cytométrie en flux | IP | ChIP | IHC |
|---|---|---|---|---|---|---|---|---|
| Humain | ||||||||
| Souris | ||||||||
| Rat |
This product is manufactured by Elabscience and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
CD19 molecule (CD19), also known as B-lymphocyte antigen CD19, is a B-cell surface glycoprotein and signalling coreceptor. This guide connects human NCBI Gene 930, UniProtKB P15391 and ABMIUM catalogue products associated with CD19.
Biological function: CD19 functions as a coreceptor for the B-cell antigen receptor complex, lowering the threshold for antigen-triggered B-cell activation. CD19 signalling can activate phosphatidylinositol 3-kinase pathways and mobilise intracellular calcium, supporting normal B-cell differentiation, proliferation and antibody responses.
